SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-208179
Filing Date
2011-08-03
Accepted
2011-08-03 16:14:58
Documents
3
Period of Report
2011-08-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 13542
2 PRESS RELEASE dex991.htm EX-99.1 104624
3 GRAPHIC g215913ex991_pg01.jpg GRAPHIC 8803
  Complete submission text file 0001193125-11-208179.txt   131859
Mailing Address 12276 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12276 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1226
Type: 8-K | Act: 34 | File No.: 000-04829 | Film No.: 111007133
SIC: 2836 Biological Products, (No Diagnostic Substances)